Merck (NYSE:MRK), known as MSD outside the United States and Canada,
today announced that BELSOMRA ® (suvorexant) is now available
at pharmacies in the United States for the treatment of insomnia in
adults who have difficulty falling asleep and/or staying asleep.
for Merck’s Insomnia Medicine BELSOMRA® (suvorexant) C-IV, the First and Only Orexin Receptor Antagonist, Now Available in the United States investment picks